Skip to main navigation Skip to search Skip to main content

TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking

  • Jianfeng Liu
  • , Bernard Johnson
  • , Ruyan Wu
  • , Robert Seaman
  • , Jimmy Vu
  • , Qing Zhu
  • , Yanan Zhang
  • , Jun Xu Li
  • SUNY Buffalo
  • Yangzhou University
  • Nantong University
  • RTI International

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Background and Purpose: The trace amine-associated receptor 1 (TAAR1) negatively modulates dopamine transmission. Our previous studies demonstrated that TAAR1 agonists attenuated cue- and drug-induced cocaine-seeking and increased the elasticity of the cocaine demand curve, in the short-access cocaine self-administration model. Compulsive use of cocaine, which is an essential criterion of cocaine use disorder, can be induced by extended access to cocaine self-administration. Experimental Approach: To characterize the role of TAAR1 in compulsive cocaine use, we evaluated the effects of activation of TAAR1 on cocaine intake, cocaine binge and cue-induced cocaine-seeking using the extended-access cocaine self-administration model in adult male Sprague–Dawley rats. We also investigated the role of TAAR1 in stress-triggered cocaine relapse by using the α2-adrenoceptor antagonist yohimbine-induced reinstatement of cocaine-seeking. Key Results: The selective TAAR1 partial agonist RO5263397 attenuated cocaine intake and did not develop tolerance during the 10-day extended-access cocaine self-administration. RO5263397 reduced a 12-h binge intake of cocaine after forced abstinence. RO5263397 also decreased cue-induced cocaine-seeking after prolonged abstinence from extended-access cocaine self-administration. Furthermore, RO5263397 and the selective TAAR1 full agonist RO5166017 reduced yohimbine-induced reinstatement of cocaine-seeking behaviour. Conclusion and Implications: Activation of TAAR1 attenuated extended-access cocaine self-administration and stress-induced cocaine reinstatement. These results suggest that TAAR1 agonists are promising pharmacological interventions to treat cocaine use disorder and relapse.

Original languageEnglish
Pages (from-to)3403-3414
Number of pages12
JournalBritish Journal of Pharmacology
Volume177
Issue number15
DOIs
StatePublished - Aug 1 2020

Fingerprint

Dive into the research topics of 'TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking'. Together they form a unique fingerprint.

Cite this